Dr. H.Krishnamurthy        

He is currently the Director of Flow cytometry facility. He obtained his PhD from the Manipal University (formerly known as Manipal Academy of Higher Education), Manipal, India (1997) in Radiation Biology. From 1997 to 2001, he underwent postdoctoral training at the Institute for Reproductive Medicine, Muenster, Germany: Institute for Clinical Research, Montreal, Canada and University of Iowa, Iowa, USA. Later, he moved to Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA as Associate Research Scientist and Managing Director of the flow cytometry facility. He was the General Secretary (Research) of The Cytometry Society, India. At present, he is working as Scientific Officer "F"and in charge of Flow Cytometry and Confocal Microscopy Facilities at the National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India. His research interest lies in hormonal regulation of spermatogenesis and trafficking and signaling of gonadotropin receptors.

Dr. Malali Gowda

He is the Director of Next Generation Genomics (NGG) facility. He was involved in establishing NGG at NCBS to facilitate the genomic and functional genomic research at Bangalore Bio-Clusters (NCBS, inSTEM, C-CAMP) and other research centers in India. Dr. Gowda’s major research area is focused on coding and non-coding RNA in plants and fungi. He is one of the international experts in rice (Oryza Sativa) and rice blast fungus (Magnaporthe oryzae). Dr. Gowda has a broad research experience in genomics, RNA biology, biodiversity and host-pathogen interactions from United States (Michigan State University, North Carolina State University and Ohio State University) and India (The Maharaja Sayajirao University of Baroda and University of Agricultural Science of Bangalore). He obtained Ph.D from M.S University, Baroda and BS/MS from UAS, Bangalore, India.

Dr. Muniasamy Neerathilingam

Dr.Muniasamy Neerathilingam (Munish) is currently the Director of Protein Technology Core.  He obtained his Doctorate (D.Phil.,) in Biochemistry from University of Oxford under the guidance of Prof. Iain D Campbell. His D.Phil work was focused mainly on the development of an expression system for structural and functional studies using the cell-free expression system, and it was claimed as a first in UK using in-house made reagents. After obtaining his D.Phil from Oxford, he moved to USA to pursue his post-doctoral work at University of Wisconsin and University of Texas for six years, where he demonstrated High-throughput cloning and expression of proteins in various systems. In addition, Munish is also specialized in NMR based metabolomics and aptamer technology. He has a few patents and a number of publications and is currently working on a few more.

Dr. Manoj V. Mathew

Dr. Manoj is the Technology Manager for Imaging facility. He obtained his B.Tech and M.Tech degrees in Electronics Engineering and Photonics respectively from the Cochin University of Science and Technology, Kerala, India. He obtained his PhD in Photonics from ICFO-The Institute of Photonic Sciences, in Barcelona, Spain and had a short stint as a post-doctoral researcher at the Gothenburg University, Sweden. At present he serves as a Technical Manger with the Centre for Cellular and Molecular Platforms, Bangalore, India and contributes to the development of optical instruments for biological imaging and manipulation in addition to participating in activities related to training and education in the use of optical instruments.

Dr. Kannan Rangiah

Dr. Kannan is the Technology Manager for Metabolomics in Mass spectrometry facility. He has done his Ph.D in International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi (2005). He has joined pharmacology department to do his postdoctoral training (from 2006 to 2011) at Center for Cancer Pharmacology, University of Pennsylvania (UPENN).  He has been exposed to different kinds of mass spec instruments (ion-trap and triple quad) to do both qualitative and quantitative experiments from various biological fluids. At present, he is working as a Technology Manager at C-CAMP. His current interest is in developing the metabolomics facility at C-CAMP and also to develop and validate mass spec based methods for the absolute quantification of bio-molecules using Stable Isotope Dilution (SID) methodology.

Dr. P. Babu

He is the Technology Manager for Glycomics in Mass spectrometry facility. Dr. P. Babu is involved in establishing the Glycomics and Glycoproteomics core and GLP/NABL compliant Biologics Characterization facility at the C-CAMP. He received his Master’s degree in chemical sciences and then obtained Ph. D from the Indian Institute of Science, Bangalore. Post-doctoral research was carried out at IISc, Bangalore, Imperial College London, UK (UKIERI Fellow) and University of Utah, Salt Lake City, USA. His research experience spans understanding the structure and functions of complex carbohydrates (glycans) under various biological contexts, including regeneration. Tandem mass spectrometry techniques in conjunction with chemical, analytical and enzymatic methods are being used to elucidate the structure of glycans (N- and O-glycans, and glycolipids) and glycosaminoglycans.  This is intended to serve the growing biopharma industry (biosimilars, biobetters and antibodies, etc.) and academia.

Dr.Giridharan Periyasamy

Dr.Giridharan is the Director of High Throughput Screening facility. He completed his PhD in 2003 in Centre for Biotechnology, Anna University. During his doctoral programme he has identified novel cancer molecule(s) from rare plant species with anti-telomerase activity. He worked as a lecturer in research at Anna University from 2003 to 2005. He was a Principal Research Consultant in the area of cancer/inflammation/metabolic drug discovery for Nicholas Piramal India Limited, Mumbai and Ranbaxy research labs in New Delhi (June 2003-July 2005). Subsequently he joined Piramal Life Sciences Ltd as Group Leader and successfully established state of art HTS facility for cell and enzyme based screening later he implemented the High Content Screening facility as part of lead evaluation and target identification.

He has hands on expertise in HTS and HCS platform for assay development, compound profiling and natural product based drug discovery for more than 10 years. He has many peer reviewed publication in various international journals and 7 US patents to his credit.

Dr. Chellappa Gopalakrishnan

Dr. Chellappa Gopalakrishnan is the Director of Bioinformatics in C-CAMP. He obtained his Ph.D. from University of Madras in Microbiology. Dr. Gopalakrishnan won the prestigious Glaxo-Wellcome and US DOE fellowship to pursue his postdoctoral work at SANBI (South African National Bioinformatics Institute) in Cape Town, South Africa. He has over fifteen years of industrial and academic experience in the Life Sciences and Bioinformatics area. He has held various positions and led many  programmes focused on building systems for Systems Biology in predictive, preventive and personalized healthcare. He was a technical contributor for large scale research-oriented bioinformatics development projects at the European Bioinformatics Institute, Hinxton, UK. Also, he was the team leader for bioinformatics platform during the Genome Canada Project, Montreal, Canada. Before moving to C-CAMP, he was heading the Bioinformatics department at Avesthagen Limited, Bangalore, India. He has served on advisory boards of Universities and Colleges. He is PMI trained US, certified six sigma UK and international lead auditor for ISMS.